Taj pharmaceuticals ltd, with increasing prevalence of respiratory diseases, erdosteine market is ex

MEDGADGET



ECHOJOURNAL

POPULAR

PASSMIX

CATEGORIES

SUBSCRIBE



SUBMIT

ABOUT

+ FOLLOW

✏ SUBMIT PR





* LOG IN









With Increasing prevalence of respiratory diseases, Erdosteine Market is Expected to Witness Highest Growth till 2024 

MARCH 10TH, 2017

 Facebook



TRANSPARENCY MARKET RESEARCH

  Twitter

  Google+

RELEASES

  LinkedIn

Erdosteine is an oral mucolytic agent used for treatment of chronic obstructive bronchitis.

Erdosteine is also used for treatment of acute and chronic bronchitis. It is an orphan drug. Erdosteine stimulates mucus production and increases mucociliary transport, which improves expectoration. It consists of two sulfhydryl groups freed after metabolic transformation in the liver.

These released sulfhydryl groups help to break the disulphide bonds. This makes bronchial secretions more fluid and enhances elimination. Erdosteine Save web pages as PDF manually or automatically w ith PDFmyURL

RECENT POSTS Jet Powered Pill Shoots Vaccine Into Cheek to Avoid Injections

shows inhibitory activity against the effects of free radicals produced by cigarette smoke. Pharmacokinetically, it acts by absorption, distribution,

ZOLL's Hospital Wearable Defibrillator FDA Approved

metabolism, and excretion. The elimination half-life of Erdosteine is about 1.46 hr. Adverse events of Erdosteine are quite low, and generally mild. It has been clinically proven that Erdosteine has good gastric tolerability after oral administration, and does not cause reflux phenomena like other thiols derivatives. Erdosteine has no direct effect on gastric mucus.

Japanese Researchers Develop New Filter to Use microRNA as Disease Biomarker

Obtain Report Details: http://www.transparencymarketresearch.com/erdosteine-market.html Increasing prevalence of respiratory diseases, rising geriatric population,

Tiny Paper Pumps to Power Microfluidic Devices

rapid population growth, and environmental pollution due to industrialization are expected to fuel the global erdosteine market. According to the WH O, chronic obstructive pulmonary disease (COPD) accounts for three million deaths globally each year and the number is expected to increase in the next few years. About 90% of chronic obstructive pulmonary disease (COPD) deaths occur in developing and underdeveloped countries. Rising

Method Spots Bacterial Infections in Root Canals to Improve Success, Prevent Additional Procedures

research and development activities, increasing health care insurance coverage, and growing adoption for treatment options are the other factors driving the global erdosteine market. On the other hand, stringent regulations for product approval are likely to hamper the growth of the global erdosteine market. Erdosteine is used for rare diseases so maximum companies doing

INTERV IEWS & REV IEWS Koogeek S1 Smart Health Scale Review

research and development which will increase the market competitiveness.

Erdosteine is marketed in over 40 countries for the treatment of various respiratory diseases.

The erdosteine market has been segmented based on dosage form, age group, application, distribution channel, and region. In terms of dosage form, the market has been classified into capsules, dry suspension, dispersible tablets, and sachets. The capsule dosage form is highly used due to ease of use, availability in unit dosage form, and also easy in term of prescription scenario

Save web pages as PDF manually or automatically w ith PDFmyURL

Medgadget's Coverage of the Inaugural AdvaMed Digital MedTech Conference

which will leads to less side effect. Based on age group, the erdosteine market has been segmented into adult and pediatric. In terms of application, the market has been classified into chronic obstructive pulmonary disease

Anders Wold, GE Healthcare’s CEO of Clinical Care Solutions on What To Think About When Running a Medtech Business

(COPD), acute bronchitis (AB), and chronic bronchitis (CB). Based on distribution channel, the erdosteine market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies.

In terms of region, the market has been segmented into N orth America, Latin

CleanSlate UV Sanitizer for Mobile Devices in Healthcare: An Interview

America, Europe, Asia Pacific, and Middle East & Africa.

Fill th e form for an exclusiv e sam ple of th is report: http://www.transparencymarketresearch.com/sample/sample.php? flag=B&rep_id=19166 N orth America dominated the erdosteine market due to rising geriatric population, early adoption of treatment procedures, and increasing prevalence of respiratory diseases. The geriatric population represents about 14.5% of the population of the U.S. According to the U.S. Department of H ealth and H uman Service, the geriatric population will increase to 98 million by 2060, which is twice that in 2014. Europe is the second largest market for erdosteine attributed to increasing research and development activities and rising number of commercial licensing partnerships for erdosteine manufacturing.

Asia Pacific is expected to grow at a higher rate driven by growing per capita expenditure, increasing health care insurance coverage, rapidly growing population, and rising per capita health care expenditure.

Major players operating in the erdosteine market include Edmond Pharma S.R.L., Alitair Pharmaceuticals, Manus Aktteva Biopharma LLP, Enaltec, Reine Life Science, Taj Pharmaceuticals Ltd., Recipharm AB, Glenmark Pharmaceuticals Ltd., Sigma-Aldrich Co. LLC, Genome Pharmaceuticals (Pvt.) Ltd., and Milan Pharma.

Save web pages as PDF manually or automatically w ith PDFmyURL

Improving Patient Engagement through Artificial Intelligence: Interview with Gilad Meiri, CEO & Co-Founder of Neura

The report offers a comprehensive evaluation of the market. It does so via indepth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Con tact us: Transparency Market Research 90 State Street, Suite 700, Albany N Y – 12207 United States Tel: +1-518-618-1030 USA – Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/

Sign up and submit a press release

RELATED POSTS

Save web pages as PDF manually or automatically w ith PDFmyURL

RELEASES

RELEASES

RELEASES

MARCH 11TH, 2017

MARCH 11TH, 2017

MARCH 11TH, 2017

Travelers Vaccines Market Growth Opportunities, Driving Factors by Manufacturers, Regions, Type and Application, Forecast Analysis to 2021

Trend Expected to Nicotine Gum Market from 2016-2021: Growth Analysis by Manufacturers, Regions, Type and Application

Hybrid-Ceramic Dental CAD/CAM Material Market In EuropeIndustry Trends, Key Players, Manufacturing Process, Machinery, Raw Materials, Cost and Revenue 2021

RELEASES

RELEASES

RELEASES

MARCH 11TH, 2017

MARCH 11TH, 2017

MARCH 11TH, 2017

Human Micobiome Market Growth Opportunities, Driving Factors by Manufacturers, Regions, Type and Application, Forecast Analysis to 2021

Fibrinogen Concentrate Market – Industry Challenges, Key Vendors, Drivers, Trends and Forecast 2021

Disposable Hemoperfusion Market In Europe- Industry Trends, Key Players, Manufacturing Process, Machinery, Raw Materials, Cost and Revenue 2021

Save web pages as PDF manually or automatically w ith PDFmyURL



SUBSCRIBE

CONTACT US

SUBMIT

ABOUT

At Medgadget we report on the latest medical technology news, interview leaders in the field, and file dispatches from medical events from around the world.

     © Medgadget, LLC. 2004-2016. All rights reserved. | The Medical Revolution Will Be Blogged.

Save web pages as PDF manually or automatically w ith PDFmyURL

BACK TO TOP

 About

 Contact

 Terms of Service

 Privacy

 Submit press release Advertise

